Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 479-950-7 | CAS number: 31274-51-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2003-08-19 - 2004-01-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD TG 429) performed under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted on 24th April 2002
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories France, L'Arbresle, France
- Age at study initiation: approximately 8 weeks old
- Body weight at study initiation: 20.5 ± 1.4 g
- Housing: individually in disposable crystal polystyrene cages (22 cm x 8.5 cm x 8 cm), each cage contained autoclaved sawdust (SICSA, Alfortville, France)
- Diet: A04 C pelleted diet (SAFE, Villemoisson, Epinay-sur-Orge, France), ad libitum
- Water: tap water (filtered using a 0.22 micron filter), ad libitum
- Acclimation period: at least 5 days before the beginning of the study
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 2 °C
- Humidity: 30 - 70 %
- Air changes: approximately 12 air changes/hour (filtered, non-recycled air)
- Photoperiod: 12 h / 12 h
IN-LIFE DATES: From: 2003-09-17 To: 2003-09-22 - Vehicle:
- propylene glycol
- Concentration:
- 0 % (control), 0.5 %, 1 %, 2.5 %, 5 %, 10 % in propylene glycol (w/v)
- No. of animals per dose:
- 4 animals per group
- Details on study design:
- MAIN STUDY
- Criteria used to consider a (lymphoproliferative) positive response: Stimulation Index (SI) > 3
TREATMENT PREPARATION AND ADMINISTRATION:
- The test item was prepared in the vehicle at the chosen concentrations and sonicated during approximately 10 minutes for the highest tested concentration (10 %). All dose formulations were made freshly on the morning of administration.
TOPICAL APPLICATION (each test group of mice):
- Topical (epidermal) application of different test item concentrations to the dorsal surface of both ears
- Application volume: 25 µL, spread over the entire dorsal surface of each ear lobe once daily for three consecutive days (on days 1, 2 and 3)
- Control animals: Application of equivalent volume of the vehicle alone
- No rinsing was performed between each application
ADMINISTRATION OF 3H-METHYL THYMIDINE (³HTdR):
- Three days before the injections, the required quantity of ³HTdR was diluted in 0.9% NaCl (20 µCi in 250 µL of 0.9% NaCl per animal). The obtained solution was stored at +4°C and protected from light before use.
OBSERVATIONS:
- Clinical signs, morbidity and mortality: once a day during the study
- Body weight: on the first day of the study (day 1) and on the day of sacrifice (day 6).
- Ear thickness measurements and recording of local reactions: On days 1, 2 and 3 (before application) as well as on day 6 (after sacrifice), the thickness of the left ear of each animal of the vehicle and treated groups was measured using a micrometer. Any irritation reaction (erythema and oedema) was recorded in parallel. Any other observation (e.g. coloration, presence of residual test item) was noted.
PROLIFERATION ASSAY / DETERMINATION OF INCORPORATED ³HTdR:
- On day 6, all animals of all groups received a single intravenous injection of 250 µL of 0.9% NaCl containing 20 µCi of ³HTdR (specific activity of 25 Ci/mmol), via the tail vein.
- Approximately 5 hours later, the animals were killed by cervical dislocation and the auricular lymph nodes were excised and pooled for each experimental group.
- For each experimental group (and the positive control group), a single cell suspension of auricular lymph node cells (ALNC) was prepared by mechanical dissagregation and measured using ß-scintillation counting. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated for the body weight.
- Positive control results:
- In the positive control group given HCA at the concentration of 25 %, an increase in cellularity and a stimulation index exceeding the threshold value of 3 (SI = 21.96) were noted. The study was therefore considered valid.
- Parameter:
- SI
- Remarks on result:
- other: Control Group: - Test Group (0.5 %): 3.98 Test Group (1 %): 0.86 Test Group (2.5 %): 1.65 Test Group (5 %): 1.17 Test Group (10 %): 1.34 Positive control group (25 % HCA): 21.96
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: dpm per node: Control Group: 61.48 dpm Test Group (0.5 %): 244.43 dpm Test Group (1 %): 53.00 dpm Test Group (2.5 %): 101.15 dpm Test Group (5 %): 71.93 dpm Test Group (10 %): 82.67 dpm Positive control group (25 % HCA): 1350.3 dpm
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Systemic clinical signs and mortality:
No clinical signs and no mortality were observed during the study.
Body weight:
The body weight change of the treated animals was similar to that of controls.
Local irritation:
No cutaneous reactions and no increase in ear thickness were observed at any of the tested concentrations
LLNA:
The quantity of cells obtained in each group was satisfactory and the cellularity correlated with incorporation of H-TdR. The cell viability was higher than 80 % in each group. In the treated groups, a positive lymphoproliferative response (SI = 3.98) was noted at the concentration of 0.5 %. However, as no positive response was present and no dose-response relationship was observed at the highest tested concentrations, this positive response could not be considered as biologically relevant. Therefore, no lymphoproliferative responses attributed to delayed contact hypersensitivity were observed during the study.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a skin sensitization study (CIT 26399, 2004, OECD 429, GLP) the potential of non-micronized ETH50 to induce delayed contact hypersensitivity was evaluated using the murine Local Lymph Node Assay (LLNA). Twenty-eight female CB A/J mice were allocated to seven groups of four animals each:
- five treated groups receiving the test item at the concentration of 0.5, 1, 2.5, 5 or 10 % in propylene glycol,
- one negative control group receiving the vehicle (propylene glycol),
- one positive control group receiving the reference item, alpha-hexylcinnamaldehyde (HCA), at the concentration of 25 %.
The test item, vehicle or reference item was applied over the ears (25 uL per ear) for 3 consecutive days (days 1, 2 and 3). After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6 and by assessment of local skin effects.
No mortality and no clinical signs were observed during the study. No cutaneous reactions and no increase in ear thickness were observed in the animals of the treated groups. A lymphoproliferative response with an SI > 3 was noted at the concentration of 0.5 % only. The SI values were 3.98, 0.86, 1.65, 1.17, 1.34 for the 0.5%, 1%, 2.5%, 5% and 10% concentration group, respectively. However, as no response and no dose-response relationship were observed up to the highest concentration tested, this response could not be considered as biologically relevant. Therefore, no lymphoproliferative responses attributed to delayed contact hypersensitivity were observed during the study. The reference item induced the appropriate response (SI: 21.96), thus demonstrating sensitivity of the test system.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The present data on dermal sensitization do not fulfill the criteria laid down in 67/548/EEC and regulation (EU) 1272/2008, and therefore, a non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.